Status:
UNKNOWN
Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
Up to 17 years
Brief Summary
Obesity is associated with a variety of comorbidities, amongst which non-alcoholic fatty liver disease (NAFLD). A recent meta-analysis has shown that the prevalence of NAFLD in obese pediatric populat...
Detailed Description
Rationale: Obesity is associated with a variety of co-morbidities. Children with obesity are more likely to have risk factors associated with cardiovascular disease (eg, hypertension, high cholesterol...
Eligibility Criteria
Inclusion
- Participation in the COACH program
- Aged below 18 years
Exclusion
- · Implanted medical devices such as pacemakers or neurostimulators
- Metal objects in the body (for instances prosthetics, piercings, metal parts in the eye, permanent eyeliner)
- Previous brain surgery
- Cardiac arrhythmia
- Epilepsy
- Claustrofobia
- Not wanting to be informed about accidental findings on MRS
Key Trial Info
Start Date :
March 31 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03787108
Start Date
March 31 2019
End Date
December 1 2019
Last Update
March 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6202AZ